SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 102 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 7.90 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $78,000 | -18.8% | 80,924 | +0.0% | 0.00% | – |
Q1 2022 | $96,000 | -70.9% | 80,884 | -20.1% | 0.00% | – |
Q4 2021 | $330,000 | +50.7% | 101,284 | +106.3% | 0.00% | – |
Q3 2021 | $219,000 | -57.6% | 49,084 | +3.1% | 0.00% | – |
Q4 2020 | $516,000 | +41.4% | 47,593 | +15.2% | 0.00% | – |
Q3 2020 | $365,000 | +52.1% | 41,303 | +83.5% | 0.00% | – |
Q2 2020 | $240,000 | -53.5% | 22,503 | -74.1% | 0.00% | – |
Q1 2020 | $516,000 | +75.5% | 87,052 | +104.8% | 0.00% | – |
Q4 2019 | $294,000 | -63.3% | 42,498 | -44.9% | 0.00% | – |
Q3 2019 | $801,000 | -39.3% | 77,156 | -45.8% | 0.00% | – |
Q2 2019 | $1,319,000 | -8.2% | 142,427 | -9.4% | 0.00% | – |
Q1 2019 | $1,437,000 | -16.7% | 157,275 | -49.3% | 0.00% | – |
Q4 2018 | $1,726,000 | -55.7% | 309,905 | -5.3% | 0.00% | -100.0% |
Q3 2018 | $3,897,000 | +16.5% | 327,214 | -0.1% | 0.00% | 0.0% |
Q2 2018 | $3,344,000 | -21.3% | 327,479 | +0.1% | 0.00% | 0.0% |
Q1 2018 | $4,248,000 | +40.8% | 327,280 | +5.6% | 0.00% | – |
Q4 2017 | $3,016,000 | -33.6% | 309,956 | +0.4% | 0.00% | -100.0% |
Q3 2017 | $4,543,000 | – | 308,660 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 881,450 | $5,677,000 | 1.32% |
IFP Advisors, Inc | 50 | $1,000 | 0.00% |
Ten Capital Wealth Advisors, LLC | 219 | $1,000 | 0.00% |